AMSILK website preview
growth sustainability Neuried 3 sources
Own this company? Claim the page to unlock editing and verified-owner badge.

AMSilk is a biotech company headquartered in Neuried near Munich that produces industrial materials based on silk proteins using precision fermentation and AI-powered protein design.

Classification

Neuried DE growth sustainability other b2b ai BiotechSustainabilitySilk ProteinsCosmeticsMedical Applications

Profile

Founded
2010
Headcount
50-100
Tech stack
AI-powered protein design, precision fermentation
Revenue range
unknown

Funding

Funding details not yet available.

Business model
💡 Value Proposition

Industrial supply of biotech silk protein materials engineered via AI and precision fermentation, redefining material excellence through nature-inspired innovation.

👥 Customer Segments

Industrial buyers seeking biotech-produced materials; B2B clients in sectors requiring high-performance, sustainable silk protein alternatives.

💰 Revenue Model

Industrial supply of materials; likely direct sales of proprietary biotech products rather than software licensing.

📡 Channels

Direct B2B sales motion; positioned as a frontrunner and distinguished Global Innovator within World Economic Forum communities.

🤝 Key Partnerships

World Economic Forum Innovator Communities; strategic alliances implied by status as a distinguished Global Innovator.

⚖️ Cost Structure

R&D for AI-powered protein design and precision fermentation processes; patent portfolio maintenance and industrial manufacturing costs.

🏗️ Key Resources

Best-in-class patent portfolio, AI-powered protein design technology, precision fermentation capabilities, and unique biogenic material science.

⚙️ Key Activities

AI-powered protein design, precision fermentation production, industrial material supply, and maintaining patent protection.

💬 Customer Relationships

B2B industrial supply relationships; leverages thought leadership and WEF recognition to establish trust and market position.

Strategic analysis
🏁 Competitive landscape

Competes in biotech material supply; differentiates through unique AI-engineered silk proteins and a best-in-class patent portfolio.

🎯 Market pains

Need for sustainable, high-performance materials; demand for nature-inspired alternatives to traditional synthetic or animal-derived resources.

💎 Improvement suggestions
  • Diversify Channel Mix with a Direct-to-Consumer (D2C) Line
🛡️ Credibility notes
  • Patented Technology & IP Depth - 185+ patent families protect core fermentation and protein-engineering processes, giving AMSilk a defens
Team
CTO
Investors

No investors recorded yet.

Sources & references

Web verified · 3 sources
Enriched 18 Jun 2026